Insider: Lewis Karen Chief People Officer - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 70,251 | 0 | 70,251 |
| Value | $1,571,514.87 | $0.00 | $1,571,514.87 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/29/2025 | DDS | 364 | Direct | COM | $29.52 | $10,746.59 | 70,251 |
| 01/22/2025 | DDS | 1,751 | Direct | COM | $30.43 | $53,275.05 | 70,615 |
| 01/17/2025 | DDS | 1,241 | Direct | COM | $29.96 | $37,178.13 | 43,858 |
| 01/13/2025 | DDS | 1,599 | Direct | COM | $28.70 | $45,894.66 | 45,099 |
| 01/30/2024 | DDS | 883 | Direct | COM | $65.53 | $57,862.99 | 46,387 |
| 01/29/2024 | DDS | 367 | Direct | COM | $64.14 | $23,538.72 | 47,270 |
| 01/23/2024 | DDS | 4,286 | Direct | COM | $63.69 | $272,975.34 | 47,637 |
| 01/22/2024 | DDS | 1,738 | Direct | COM | $65.00 | $112,963.05 | 51,923 |
| 01/17/2024 | DDS | 3,276 | Direct | COM | $65.58 | $214,840.08 | 53,661 |
| 01/16/2024 | DDS | 1,632 | Direct | COM | $66.81 | $109,031.64 | 56,937 |
| 06/01/2023 | DDS | 5,000 | Direct | COM | $86.00 | $430,000.00 | 41,504 |
| 04/03/2023 | DDS | 5,000 | Direct | COM | $75.00 | $375,000.00 | 41,430 |
| 02/23/2023 | DDS | 1,104 | Direct | COM | $68.76 | $75,911.04 | 41,430 |
| 01/30/2023 | DDS | 883 | Direct | COM | $52.76 | $46,587.08 | 36,459 |
| 01/23/2023 | DDS | 2,955 | Direct | COM | $51.58 | $152,418.90 | 37,709 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research